Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07640061 · ClinicalTrials.gov registry record · Phase 1
Pilot Studies Testing the Use of Oral Amitriptyline in Reducing Localized Burn Injury-induced Microvesicle Particle Release
A Phase 1 study, sponsored by Wright State University.
- Not yet
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT07640061 is a Phase 1 study that has not yet begun recruiting, run by Wright State University. The registered enrollment target is 20 participants.
The verdict
NCT07640061, a Phase 1 study, has not yet begun recruiting, sponsored by Wright State University.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the amount of substances contained in skin known as microvesicle particles (MVP). The hypothesis to be tested in this study is that treatment with a single dose of 75mg of amitriptyline will block the MVP released from the skin from a very small localized burn injury.
Interventions
- DRUG Placebo
- DRUG Amitriptyline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2027-06 |
| Est. Completion | 2033-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07640061
The ClinicalTrials.gov registry entry for NCT07640061 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wright State University, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07640061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07640061 about?
NCT07640061 is a clinical study titled "Pilot Studies Testing the Use of Oral Amitriptyline in Reducing Localized Burn Injury-induced Microvesicle Particle Release". The purpose of this study is to determine the amount of substances contained in skin known as microvesicle particles (MVP). The hypothesis to be tested in this study is that treatment with a single dose of 75mg of amitriptyline will block the MVP released from the skin from a very small localized bu...
What is the current status of trial NCT07640061?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2027-06. Estimated completion is 2033-06.
What interventions are being tested in trial NCT07640061?
The interventions under investigation include: Placebo (DRUG), Amitriptyline (DRUG).
Who is sponsoring clinical trial NCT07640061?
This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.